SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-026567
Filing Date
2020-05-21
Accepted
2020-05-21 16:31:02
Documents
8
Period of Report
2020-05-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K onct-8k_20200519.htm 8-K 55507
2 EX-4.1 onct-ex41_7.htm EX-4.1 143150
3 EX-4.2 onct-ex42_8.htm EX-4.2 134602
4 EX-5.1 onct-ex51_14.htm EX-5.1 17833
5 EX-10.1 onct-ex101_9.htm EX-10.1 247284
6 EX-10.2 onct-ex102_10.htm EX-10.2 86089
7 EX-99.1 onct-ex991_11.htm EX-99.1 18566
8 GRAPHIC gl2dvtpyktew000001.jpg GRAPHIC 7279
  Complete submission text file 0001564590-20-026567.txt   714536
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 20902278
SIC: 2834 Pharmaceutical Preparations